2023
DOI: 10.1111/imm.13666
|View full text |Cite
|
Sign up to set email alerts
|

Activation of Inflammasome complex in nasopharyngeal epithelial cells from patients with Coronavirus disease 2019 contributes to inflammatory state and worse disease outcomes

Abstract: Pathogenesis of Coronavirus disease 2019 (COVID‐19) has been associated with dysregulation of both adaptive and innate immune systems. Hence, we determined the contribution of inflammasome in the nasopharyngeal epithelial cells isolated from COVID‐19 subjects to disease pathogenesis and outcomes. Epithelial cells from 150 COVID‐19 patients and 150 healthy controls were yielded through nasopharyngeal swab sampling. Patients were categorized into three groups of those with clinical presentations/need hospitaliza… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 24 publications
(28 reference statements)
0
1
0
Order By: Relevance
“…Our previous research had indicated aberrant expression of inflammasome-related genes [ 16 ] as well as Toll-like receptors (TLRs) [ 17 , 18 ] in the nasopharyngeal epithelial cells from COVID-19 subjects that might be of importance in determining the intensity of the disease’s severity. In this study, the expression of NLRP1, NLRP3, and ASC and their association with serum level of IL-1β were explored in COVID-19 patients.…”
Section: Discussionmentioning
confidence: 99%
“…Our previous research had indicated aberrant expression of inflammasome-related genes [ 16 ] as well as Toll-like receptors (TLRs) [ 17 , 18 ] in the nasopharyngeal epithelial cells from COVID-19 subjects that might be of importance in determining the intensity of the disease’s severity. In this study, the expression of NLRP1, NLRP3, and ASC and their association with serum level of IL-1β were explored in COVID-19 patients.…”
Section: Discussionmentioning
confidence: 99%